You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
睿智醫藥(300149.SZ):回購期限屆滿暨股份回購未達回購計劃下限及致歉
格隆匯 01-21 21:13

格隆匯1月21日丨睿智醫藥(300149.SZ)公佈,此前披露,公司擬使用自有資金以集中競價交易的方式回購公司部分社會公眾股,用於實施股權激勵計劃或員工持股計劃。此次回購資金總額不低於人民幣5000萬元(含)且不超過10000萬元(含),回購價不超人民幣20元/股(含),回購期限為自董事會審議通過之日起12個月內。

自公司董事會審議通過回購方案之後,公司根據資金情況,計劃分階段實施回購。截至公吿日,公司回購股份的累計使用資金約2550.12萬元(不含交易費用),與回購方案中計劃回購下限5000萬元相差2449.88萬元,實際回購總金額是回購方案計劃金額下限的51%。公司回購總金額未達到回購方案中擬回購金額的下限,主要是由於公司部分建設項目投入資金較多,外部融資進度未及預期。

為保障公司正常經營活動,維護公司及全體股東長遠利益,公司決定對資金採用謹慎使用、合理投入的策略,優先將自有資金用於日常經營和戰略佈局,暫且放緩回購進度,因而導致公司實際回購金額與回購方案計劃金額出現偏差。公司對此次回購未達到回購方案中擬回購金額的下限給公司和市場帶來的不良影響,向廣大投資者致以誠摯的歉意,今後將加強資金規劃,信守承諾,堅決杜絕此類事件的再次發生。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account